Medtronic's Q1 revenue beats estimates, raises FY outlook
MDT•Outlook
- Medtronic raises FY27 organic revenue growth guidance to 7.25% to 7.75%
- Company lifts FY27 diluted non-GAAP EPS guidance to $5.94-$6.00
- Guidance includes estimated neutral to 1% accretive impact from foreign currency exchange
Overview
- Healthcare technology firm's fiscal Q1 revenue rose 13.7%, beating analyst expectations
- Adjusted EPS for fiscal Q1 rose 15.1%
- Company raised FY27 revenue and EPS guidance after broad-based portfolio growth
Result drivers
- Cardiovascular growth - Co said Q1 results were led by 18.9% organic growth in Cardiovascular, with strong gains in Cardiac Rhythm Management and Cardiac Ablation Solutions
- Portfolio breadth - Co attributed results to broad-based performance across largest franchises and new growth platforms
- Extra fiscal week - Co said Q1 organic growth benefited by about $570 mln due to an extra fiscal week
Key details and analyst coverage
| Metric |
|---|
